Cardiovascular and renal developments: patent highlights January to June 2006

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Pharmaceutical Science

Background:

• Cardiovascular diseases are a leading cause of death and chronic illness in industrialized nations.
• Aging exacerbates conditions such as hypertension, atherosclerosis, myocardial infarction, heart failure, and cardiac arrhythmia.
• Novel therapeutic strategies are urgently needed to address the growing burden of cardiovascular and renal diseases.

Purpose of the Study:

• To summarize key developments in cardiovascular and renal patents from the first half of 2006.
• To identify emerging therapeutic targets and drug candidates.
• To highlight innovations beyond drug formulations and combinations.

Main Methods:

• Review of cardiovascular and renal patents published in the first half of 2006.
• Exclusion of patents solely focused on formulations or combinations of existing drugs.
• Analysis of patent content for novel therapeutic targets and drug discovery approaches.

Main Results:

• Identification of significant patent activity in cardiovascular and renal therapeutics.
• Emergence of new targets for treating hypertension, atherosclerosis, myocardial infarction, heart failure, and cardiac arrhythmia.
• Focus on innovative approaches to drug discovery and patient response monitoring.

Conclusions:

• The pharmaceutical industry is actively pursuing novel therapeutic targets and drugs for cardiovascular and renal diseases.
• Patent trends indicate a drive towards fundamentally new treatment modalities.
• Continued innovation is essential to combat cardiovascular mortality and morbidity.